Bonn/Brussels – The newly launched European Partnership for Personalised Medicine (EP PerMed) aims to improve future healthcare for all citizens through personalised therapy, diagnosis and prevention. With a total budget of around €375 million, provided by the EU and more than 50 international partners, EP PerMed will not only significantly support the transnational development of personalised medicine approaches over the next ten years, but also their successful translation into clinical practice. A preliminary announcement for the first joint transnational call for proposals has now been published.
The European Partnership for Personalised Medicine brings together ministries, funding organisations and research institutes from 24 countries and 10 European regions. EP PerMed builds on the results and experience of several international initiatives and projects in the field of personalised medicine, as well as more than 15 years of successful collaboration among many of the partners involved. Over the next ten years (2023-2033), most of EP PerMed’s budget will be available for funding of research projects and the implementation of personalised medicine approaches.
More information on the European Partnership for Personalised Medicine can be found here: https://www.eppermed.eu